A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
In: Annals of Oncology, Jg. 28 (2017-11-01), Heft 11, S. 2901-2902
Online
academicJournal
Titel: |
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
|
---|---|
Autor/in / Beteiligte Person: | Cherny, N I ; Sullivan, R ; Dafni, U ; Kerst, J M ; Sobrero, A ; Zielinski, C ; de Vries, E G E ; Piccart, M J |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 28 (2017-11-01), Heft 11, S. 2901-2902 |
Veröffentlichung: | 2017 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (print) |
DOI: | 10.1093/annonc/mdw258 |
Sonstiges: |
|